NASDAQ:CUTR - Cutera Stock Price, Price Target & More

$51.30 0.00 (0.00 %)

(As of 04/23/2018 09:00 AM ET)

Previous Close$51.30

Today's Range$51.10 - $52.00

52-Week Range$18.50 - $55.00

Volume122,600 shs

Average Volume174,758 shs

Market Capitalization$696.81 million

P/E Ratio67.50

Dividend YieldN/A

Beta0.45

About Cutera (NASDAQ:CUTR)

Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; solera console platform, including Opus and Titan consoles; and CoolGlide systems, as well as provides myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; skin care products; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

Receive CUTR News and Ratings via Email

Sign-up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment

Sub-IndustryN/A

SectorComputer and Technology

SymbolNASDAQ:CUTR

CUSIPN/A

Webwww.cutera.com

Phone415-657-5500

Debt

Debt-to-Equity RatioN/A

Current Ratio2.04%

Quick Ratio1.38%

Price-To-Earnings

Trailing P/E Ratio67.50

Forward P/E Ratio84.10

P/E Growth2

Sales & Book Value

Annual Sales$151.49 million

Price / Sales4.60

Cash Flow$0.8851 per share

Price / Cash57.96

Book Value$4.68 per share

Price / Book10.96

Profitability

EPS (Most Recent Fiscal Year)$0.77

Net Income$29.99 million

Net Margins19.80%

Return on Equity18.31%

Return on Assets11.39%

Miscellaneous

Employees367

Outstanding Shares13,580,000

How to Become a New Pot Stock Millionaire

Cutera (NASDAQ:CUTR) Frequently Asked Questions

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

How will Cutera's stock buyback program work?

Cutera declared that its board has authorized a share buyback plan on Tuesday, August 8th 2017, which authorizes the company to repurchase $25,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its shares are undervalued.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) released its quarterly earnings data on Wednesday, February, 14th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.09. The medical device company had revenue of $47.60 million for the quarter, compared to analyst estimates of $43.96 million. Cutera had a return on equity of 18.31% and a net margin of 19.80%. Cutera's revenue was up 25.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.30 EPS. View Cutera's Earnings History.

When is Cutera's next earnings date?

Cutera is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for Cutera.

What guidance has Cutera issued on next quarter's earnings?

Cutera issued an update on its FY18 earnings guidance on Wednesday, February, 14th. The company provided earnings per share (EPS) guidance of $1.03-1.11 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.00. The company issued revenue guidance of $178-181 million, compared to the consensus revenue estimate of $166.90 million.

What price target have analysts set for CUTR?

6 equities research analysts have issued twelve-month price objectives for Cutera's shares. Their predictions range from $32.00 to $60.00. On average, they anticipate Cutera's share price to reach $45.40 in the next twelve months. View Analyst Ratings for Cutera.

What are Wall Street analysts saying about Cutera stock?

Here are some recent quotes from research analysts about Cutera stock:

1. According to Zacks Investment Research, "Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system. " (4/18/2018)
2. Gabelli analysts commented, "As a leading laser dermatology company, Cutera is an attractive long-term investment as management focuses on execution, growing sales and improving operating performance. Throughout 2017, Cutera revamped several members of its management team, including its CEO and CFO, along with several new hires to build out its sales and operational infrastructure in the US and internationally. Management is putting in place new processes to improve upon product development and scale up its organization for sustainable growth." (2/16/2018)
3. Maxim Group analysts commented, "3Q17 total revenue of $38.2M, up 26.1% y/y, was above both our estimate of $35.6M and consensus of $34.7M. North America product revenue grew 57.4% y/y, while international product revenue grew just 0.1% y/y." (11/8/2017)

Who are some of Cutera's key competitors?

Some companies that are related to Cutera include AxoGen (AXGN), Natus Medical (BABY), Viewray (VRAY), Rockwell Medical (RMTI), Vision Sciences (CGNT), Helius Medical Technologies (HSDT), Zynex (ZYXI), Biolife Solutions (BLFS), Second Sight Medical (EYES), Viveve Medical (VIVE), Edap Tms (EDAP), IRIDEX (IRIX), BioSig Technologies (BSGM), Soleno Therapeutics (SLNO), Digirad (DRAD), Dynatronics (DYNT), Aradigm (ARDM) and EnteroMedics (RSLS).

Who are Cutera's key executives?

Cutera's management team includes the folowing people:

Mr. Larry E. Laber, Exec. VP of Sales - North America (Age 47)
Mr. Ronald J. Santilli, Exec. Officer (Age 58)
Mr. James A. Reinstein, CEO, Pres & Director (Age 53)
Ms. Sandra A. Gardiner, Exec. VP & CFO (Age 52)
Dr. Michael Karavitis Ph.D., Exec. VP & Chief Technology Officer

Has Cutera been receiving favorable news coverage?

Headlines about CUTR stock have trended somewhat positive on Monday, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Cutera earned a media sentiment score of 0.14 on Accern's scale. They also assigned media coverage about the medical device company an impact score of 47.59 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Cutera?

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $51.30.

How big of a company is Cutera?

Cutera has a market capitalization of $696.81 million and generates $151.49 million in revenue each year. The medical device company earns $29.99 million in net income (profit) each year or $0.77 on an earnings per share basis. Cutera employs 367 workers across the globe.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]

MarketBeat Community Rating for Cutera (CUTR)

Community Ranking:		2.7 out of 5 ( )
Outperform Votes:		168 (Vote Outperform)
Underperform Votes:		145 (Vote Underperform)
Total Votes:		313

MarketBeat's community ratings are surveys of what our community members think about Cutera and other stocks. Vote "Outperform" if you believe CUTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CUTR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Cutera (NASDAQ:CUTR) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

6 Wall Street analysts have issued ratings and price targets for Cutera in the last 12 months. Their average twelve-month price target is $45.40, suggesting that the stock has a possible downside of 11.50%. The high price target for CUTR is $60.00 and the low price target for CUTR is $32.00. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.67	2.80	2.75	2.75
Ratings Breakdown:	0 Sell Rating(s) 2 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$45.40	$43.00	$37.3333	$37.3333
Price Target Upside:	11.50% downside	15.02% downside	4.15% downside	5.37% downside

Cutera (NASDAQ:CUTR) Consensus Price Target History

Price Target History for Cutera (NASDAQ:CUTR)

Cutera (NASDAQ:CUTR) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/16/2018	Stifel Nicolaus	Initiated Coverage	Hold -> Hold	$55.00	High
3/13/2018	Stephens	Initiated Coverage	Overweight	$60.00	High
2/16/2018	Gabelli	Reiterated Rating	Buy		Low
11/8/2017	Maxim Group	Reiterated Rating	Hold		N/A
9/12/2017	Roth Capital	Boost Price Target	Buy	$41.00 -> $47.00	High
7/7/2017	Sidoti	Reiterated Rating	Buy	$30.00 -> $32.00	Medium

(Data available from 4/23/2016 forward)

Cutera (NASDAQ:CUTR) Earnings History and Estimates Chart

Earnings by Quarter for Cutera (NASDAQ:CUTR)

Cutera (NASDAQ:CUTR) Earnings Estimates

Current Year EPS Consensus Estimate: $0.61 EPS
Next Year EPS Consensus Estimate: $1.01 EPS

Cutera (NASDAQ CUTR) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/8/2018		$0.01					N/A
2/14/2018	Q4 2017	$0.33	$0.42	$43.96 million	$47.60 million	View	Listen
11/7/2017	Q3 2017	$0.08	$0.42	$34.82 million	$38.17 million	View	N/A
8/7/2017	Q2 2017	$0.03	$0.13	$32.08 million	$36.40 million	View	Listen
5/1/2017	Q1 2017	($0.07)	($0.07)	$29.00 million	$29.30 million	View	Listen
2/13/2017	Q4 2016	$0.27	$0.30	$38.00 million	$37.90 million	View	Listen
11/7/2016	Q3	$0.04	$0.12	$28.84 million	$30.30 million	View	Listen
8/1/2016	Q2	($0.01)	$0.07	$26.20 million	$27.50 million	View	Listen
5/2/2016	Q1	($0.12)	($0.16)	$21.62 million	$22.40 million	View	Listen
2/8/2016	Q4	$0.11	$0.25	$29.59 million	$30.00 million	View	Listen
11/2/2015	Q315	($0.12)	($0.07)	$21.87 million	$23.10 million	View	Listen
8/5/2015	Q215	($0.13)	($0.13)	$21.41 million	$22.56 million	View	Listen
5/7/2015	Q115	($0.13)	($0.25)	$18.70 million	$19.07 million	View	Listen
2/5/2015	Q414	$0.08	($0.01)	$24.56 million	$25.50 million	View	Listen
11/3/2014	Q314	($0.13)	($0.18)	$18.10 million	$18.70 million	View	Listen
8/4/2014	Q214	($0.08)	($0.19)	$19.69 million	$17.72 million	View	Listen
5/8/2014	Q114	($0.12)	($0.26)	$17.02 million	$16.20 million	View	Listen
2/11/2014	Q413	($0.01)	($0.02)	$21.70 million	$22.20 million	View	Listen
11/4/2013	Q313	($0.03)	($0.11)	$20.96 million	$16.80 million	View	Listen
8/5/2013	Q2 2013	($0.02)	($0.04)	$21.70 million	$149.60 million	View	Listen
5/6/2013	Q1 2013	($0.11)	($0.15)	$18.29 million	$15.97 million	View	Listen
2/11/2013	Q4 2012	$0.02	$0.08	$22.07 million	$22.50 million	View	Listen
11/5/2012	Q312	($0.11)	($0.06)	$18.87 million	$19.40 million	View	N/A
8/6/2012		($0.10)	($0.10)			View	N/A
5/10/2012		($0.26)	($0.38)			View	N/A
2/13/2012		($0.08)	($0.06)			View	N/A
11/7/2011		($0.16)	($0.21)			View	N/A
8/1/2011		($0.20)	($0.18)			View	N/A
5/2/2011		($0.15)	($0.28)			View	N/A
2/2/2011		($0.12)	($0.09)			View	N/A
11/1/2010	Q3 2010	($0.18)	($0.25)			View	N/A
8/2/2010	Q2 2010	($0.09)	($0.28)			View	N/A
5/3/2010	Q1 2010	($0.05)	($0.15)			View	N/A
11/2/2009	Q3 2009	($0.06)	($0.09)			View	N/A
8/3/2009	Q2 2009	($0.08)	($0.18)			View	N/A
5/4/2009	Q1 2009	($0.06)	($0.10)			View	N/A
2/9/2009	Q4 2008	$0.01	$0.08			View	N/A
11/3/2008	Q3 2008	$0.12	($0.03)			View	N/A
8/4/2008	Q2 2008	$0.11	$0.05			View	N/A
5/6/2008	Q1 2008	$0.18	($0.04)			View	N/A
2/11/2008	Q4 2007	$0.40	$0.27			View	N/A

(Earnings results data provided by Zacks Investment Research)

Cutera (NASDAQ:CUTR) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Cutera (NASDAQ CUTR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.30%
Institutional Ownership Percentage: 96.48%

Insider Trading History for Cutera (NASDAQ:CUTR)

Institutional Ownership by Quarter for Cutera (NASDAQ:CUTR)

Cutera (NASDAQ CUTR) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/2/2018	James A Reinstein	Insider	Sell	7,175	$45.35	$325,386.25	132,284
1/2/2018	Larry Laber	EVP	Sell	5,843	$45.35	$264,980.05	79,463
12/18/2017	David B Apfelberg	Director	Sell	1,000	$47.40	$47,400.00	8,259
12/12/2017	Miguel Pardos	EVP	Sell	10,000	$46.70	$467,000.00	39,698
11/17/2017	David B Apfelberg	Director	Sell	1,000	$42.55	$42,550.00	8,055
11/15/2017	Larry Laber	EVP	Sell	1,250	$44.30	$55,375.00	70,463
11/8/2017	Larry Laber	EVP	Sell	1,700	$42.15	$71,655.00	72,413
11/6/2017	Larry Laber	EVP	Sell	500	$41.50	$20,750.00	72,413
11/6/2017	Timothy J Oshea	Director	Sell	4,000	$41.00	$164,000.00	36,467
10/18/2017	David B Apfelberg	Director	Sell	1,000	$39.90	$39,900.00	10,259
10/16/2017	Larry Laber	EVP	Sell	500	$40.50	$20,250.00	73,382
10/16/2017	Timothy J Oshea	Director	Sell	4,000	$39.21	$156,840.00
9/18/2017	David B. Apfelberg	Director	Sell	1,000	$38.45	$38,450.00
9/11/2017	Ronald J Santilli	CFO	Sell	5,775	$40.43	$233,483.25	50,012
8/30/2017	Miguel Pardos	EVP	Sell	5,000	$36.00	$180,000.00	39,698
8/22/2017	Ronald J Santilli	EVP	Sell	2,947	$34.00	$100,198.00	58,308
8/17/2017	Ronald J Santilli	EVP	Sell	28,519	$34.01	$969,931.19	75,253
8/16/2017	Ronald J Santilli	CFO	Sell	12,000	$34.00	$408,000.00	75,253
8/15/2017	Ronald J Santilli	EVP	Sell	1,068	$33.20	$35,457.60	87,253
6/28/2017	Larry Laber	EVP	Sell	1,000	$25.88	$25,880.00	73,140
6/26/2017	David A Gollnick	Director	Sell	10,000	$25.08	$250,800.00	26,641
6/26/2017	Larry Laber	EVP	Sell	500	$25.50	$12,750.00	73,140
6/16/2017	Timothy J Oshea	Director	Sell	4,000	$39.21	$156,840.00	40,213
6/12/2017	Larry Laber	EVP	Sell	2,563	$24.36	$62,434.68	74,203
6/1/2017	Larry Laber	EVP	Sell	957	$22.95	$21,963.15	76,203
6/1/2017	Ronald J Santilli	CFO	Sell	3,857	$22.95	$88,518.15	88,321
5/25/2017	Larry Laber	EVP	Sell	6,482	$22.89	$148,372.98	80,642
5/24/2017	David A Gollnick	Director	Sell	39,204	$22.31	$874,641.24	34,136
5/9/2017	Ronald J Santilli	CFO	Sell	20,856	$19.90	$415,034.40	92,178
5/8/2017	Ronald J Santilli	CFO	Sell	60,991	$19.99	$1,219,210.09	174,025
4/24/2017	Larry Laber	EVP	Sell	6,824	$20.66	$140,983.84	82,100
4/20/2017	Miguel Pardos	EVP	Sell	5,000	$21.00	$105,000.00	44,698
4/19/2017	Larry Laber	EVP	Sell	2,176	$20.54	$44,695.04	78,852
4/10/2017	Miguel Pardos	EVP	Sell	5,000	$20.00	$100,000.00	44,698
4/3/2017	Miguel Pardos	EVP	Sell	5,000	$20.73	$103,650.00	44,698
3/13/2017	J Daniel Plants	Director	Sell	250,000	$20.25	$5,062,500.00	5,550
3/3/2017	David A Gollnick	Director	Sell	25,000	$20.40	$510,000.00	73,340
2/21/2017	Larry Laber	EVP	Sell	1,500	$21.97	$32,955.00	72,665
11/30/2016	David A Gollnick	Director	Sell	17,914	$17.01	$304,717.14	99,940
11/14/2016	Ronald J Santilli	CEO	Sell	53,346	$14.05	$749,511.30	125,958
6/7/2016	Kevin P Connors	CEO	Sell	21,606	$10.29	$222,325.74	657,484
6/2/2016	Kevin P Connors	CEO	Sell	33,098	$10.58	$350,176.84	645,478
5/4/2016	Kevin P Connors	CEO	Sell	65,296	$11.37	$742,415.52	686,001
5/3/2016	Kevin P Connors	CEO	Sell	13,172	$11.45	$150,819.40	686,001
5/2/2016	Kevin P Connors	CEO	Sell	42,123	$11.32	$476,832.36	686,001
3/4/2016	Jerry P Widman	Director	Sell	12,000	$12.01	$144,120.00	43,723
9/4/2015	Ronald J. Santilli	CFO	Sell	31,599	$15.00	$473,985.00	71,945
8/18/2015	Ronald J. Santilli	CFO	Sell	5,459	$15.02	$81,994.18	71,945
8/17/2015	Ronald J Santilli	CFO	Sell	17,942	$15.02	$269,488.84
6/22/2015	David A Gollnick	Director	Sell	6,448	$15.04	$96,977.92
6/8/2015	Jerry P Widman	Director	Sell	10,000	$14.95	$149,500.00
6/3/2015	David A Gollnick	Director	Sell	12,212	$15.00	$183,180.00
6/3/2015	Ronald J Santilli	CFO	Sell	31,752	$14.99	$475,962.48
6/2/2015	David B Apfelberg	Director	Sell	10,000	$14.99	$149,900.00
6/2/2015	Ronald J Santilli	CFO	Sell	4,192	$15.00	$62,880.00
6/1/2015	David A Gollnick	Director	Sell	15,406	$15.00	$231,090.00
6/1/2015	Kevin P Connors	CEO	Sell	5,010	$14.90	$74,649.00
6/1/2015	Ronald J Santilli	CFO	Sell	19,663	$14.98	$294,551.74
5/12/2015	David B Apfelberg	Director	Sell	7,000	$14.08	$98,560.00
4/24/2015	David A Gollnick	Director	Sell	1,961	$14.17	$27,787.37
4/13/2015	Kevin P Connors	CEO	Sell	33,596	$13.41	$450,522.36
3/30/2015	Kevin P Connors	CEO	Sell	99,704	$13.11	$1,307,119.44
3/9/2015	Jerry P Widman	Director	Sell	7,000	$13.12	$91,840.00
3/2/2015	Ronald J Santilli	CFO	Sell	63,700	$13.35	$850,395.00
2/24/2015	Clinton Severson	Director	Buy	4,000	$12.50	$50,000.00
2/22/2013	David B Apfelberg	Director	Sell	16,211	$12.55	$203,448.05
8/23/2012	Timothy J Oshea	Director	Sell	2,700	$7.47	$20,169.00
8/21/2012	Kevin P Connors	CEO	Buy	12,000	$7.29	$87,480.00

(Data available from 1/1/2013 forward)

Cutera (NASDAQ CUTR) News Headlines

Source:

Date	Headline
	Cutera (CUTR) Upgraded to Strong-Buy by BidaskClub www.americanbankingnews.com - April 19 at 11:03 AM
	Zacks Investment Research Downgrades Cutera (CUTR) to Hold www.americanbankingnews.com - April 18 at 10:16 PM
	Cutera (CUTR) Research Coverage Started at Stifel Nicolaus www.americanbankingnews.com - April 16 at 5:24 PM
	Cutera (CUTR) Downgraded to "Hold" at BidaskClub www.americanbankingnews.com - April 14 at 7:21 AM
	Head to Head Comparison: Cutera (CUTR) and Its Peers www.americanbankingnews.com - April 14 at 1:13 AM
	Cutera, Inc. (CUTR) Given Consensus Rating of "Buy" by Analysts www.americanbankingnews.com - April 13 at 1:41 AM
	Cutera Celebrates 20 Years of Best-In-Class Product Innovation finance.yahoo.com - April 12 at 8:33 AM
	Cutera, Inc. to Announce First Quarter 2018 Results finance.yahoo.com - April 11 at 8:27 AM
	Financial Review: Cutera (CUTR) vs. Its Rivals www.americanbankingnews.com - April 10 at 9:14 PM
	Critical Review: Cutera (CUTR) & The Competition www.americanbankingnews.com - April 8 at 1:17 AM
	Cutera (CUTR) Upgraded by BidaskClub to "Strong-Buy" www.americanbankingnews.com - April 7 at 7:02 AM
	Critical Review: Masimo (MASI) vs. Cutera (CUTR) www.americanbankingnews.com - April 3 at 3:12 PM
	Cutera (CUTR) & Its Rivals Financial Comparison www.americanbankingnews.com - April 2 at 5:28 AM
	Edited Transcript of CUTR earnings conference call or presentation 14-Feb-18 9:30pm GMT finance.yahoo.com - April 1 at 8:17 AM
	Head to Head Analysis: Cutera (CUTR) and Its Rivals www.americanbankingnews.com - March 31 at 5:10 PM
	Financial Review: MTS Systems (MTSC) versus Cutera (CUTR) www.americanbankingnews.com - March 30 at 1:34 AM
	Cutera (CUTR) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - March 29 at 11:29 AM
	Critical Comparison: Cutera (CUTR) & Its Rivals www.americanbankingnews.com - March 27 at 7:22 PM
	Cutera (CUTR) versus Its Rivals Financial Survey www.americanbankingnews.com - March 25 at 9:22 AM
	Cutera (CUTR) versus Lumentum (LITE) Financial Contrast www.americanbankingnews.com - March 21 at 5:33 PM
	Cutera to Present at the Sidoti Spring 2018 Investor Conference finance.yahoo.com - March 20 at 8:24 AM
	Financial Survey: Cutera (CUTR) vs. The Competition www.americanbankingnews.com - March 19 at 11:50 AM
	Cutera, Inc. (CUTR) Receives Average Recommendation of "Buy" from Brokerages www.americanbankingnews.com - March 19 at 1:53 AM
	Stephens Begins Coverage on Cutera (CUTR) www.americanbankingnews.com - March 18 at 11:15 AM
	BidaskClub Upgrades Cutera (CUTR) to Strong-Buy www.americanbankingnews.com - March 17 at 6:44 PM
	BRIEF-Cutera Inc Files For Non-Timely 10-K - SEC Filing www.reuters.com - March 17 at 8:23 AM
	Cutera (CUTR) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow seekingalpha.com - March 17 at 8:23 AM
	Cutera, Inc. (CUTR) Holdings Trimmed by Martingale Asset Management L P www.americanbankingnews.com - March 4 at 12:50 PM
	Cutera, Inc. (CUTR) Shares Bought by Bogle Investment Management L P DE www.americanbankingnews.com - March 3 at 4:52 AM
	Cortina Asset Management LLC Purchases New Stake in Cutera, Inc. (CUTR) www.americanbankingnews.com - March 2 at 1:32 PM
	Spark Investment Management LLC Decreases Position in Cutera, Inc. (CUTR) www.americanbankingnews.com - February 27 at 4:35 PM
	EAM Investors LLC Sells 45,993 Shares of Cutera, Inc. (CUTR) www.americanbankingnews.com - February 27 at 3:00 PM
	Cutera, Inc. (CUTR) Holdings Lessened by Fuller & Thaler Asset Management Inc. www.americanbankingnews.com - February 27 at 1:06 PM
	Cutera, Inc. (CUTR) Receives Consensus Recommendation of "Buy" from Analysts www.americanbankingnews.com - February 22 at 1:42 AM
	Cutera (CUTR) Upgraded at Zacks Investment Research www.americanbankingnews.com - February 21 at 10:00 PM
	Cutera, Inc. to Post FY2022 Earnings of $2.30 Per Share, Gabelli Forecasts (CUTR) www.americanbankingnews.com - February 19 at 9:34 AM
	Gabelli Reaffirms Buy Rating for Cutera (CUTR) www.americanbankingnews.com - February 16 at 4:20 PM
	Cutera's (CUTR) CEO James Reinstein on Q4 2017 Results - Earnings Call Transcript seekingalpha.com - February 15 at 5:22 PM
	Cutera (CUTR) Releases Earnings Results, Beats Estimates By $0.09 EPS www.americanbankingnews.com - February 15 at 10:08 AM
	Cutera Reports Fourth Quarter and Full Year 2017 Record Revenue and Financial Results finance.yahoo.com - February 15 at 9:44 AM
	Cutera Showcases Expanded Portfolio at AAD finance.yahoo.com - February 15 at 9:44 AM
	Cutera (CUTR) Issues FY18 Earnings Guidance www.americanbankingnews.com - February 14 at 5:46 PM
	Cutera (CUTR) Scheduled to Post Earnings on Monday www.americanbankingnews.com - February 5 at 3:26 AM
	Cutera, Inc. (CUTR) Receives Average Recommendation of "Buy" from Analysts www.americanbankingnews.com - January 28 at 1:50 AM
	Commit To Buy Cutera At $45, Earn 16.5% Annualized Using Options www.nasdaq.com - January 23 at 5:26 PM
	Cutera, Inc. to Announce Fourth Quarter and Full-Year 2017 Results finance.yahoo.com - January 17 at 9:59 AM
	Short Interest in Cutera, Inc. (CUTR) Grows By 33.4% www.americanbankingnews.com - January 14 at 2:34 AM
	Cutera (CUTR) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - January 9 at 8:58 PM
	Cutera Enters Two New Aesthetic Markets With Launch Of New Products www.prnewswire.com - January 8 at 9:25 AM
	Larry Laber Sells 5,843 Shares of Cutera, Inc. (CUTR) Stock www.americanbankingnews.com - January 4 at 7:56 PM

Cutera (NASDAQ:CUTR) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Cutera (NASDAQ:CUTR) Income Statement, Balance Sheet and Cash Flow Statement

Cutera (NASDAQ CUTR) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff